Clinical Outcomes and Disease Progression among Patients Coinfected with HIV and Human T Lymphotropic Virus Types 1 and 2

This publication has 28 references indexed in Scilit:

• Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil
  AIDS, 2001
• Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA
  AIDS, 2001
• Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II
  Journal of Clinical Virology, 2001
• High Rate of Human T Lymphotropic Virus Type IIa Infection in HIV Type 1-Infected Intravenous Drug Abusers in Ireland
  AIDS Research and Human Retroviruses, 1999
• An International Collaborative Study of the Effects of Coinfection with Human T-Lymphotropic Virus Type II on Human Immunodeficiency Virus Type 1 Disease Progression in Injection Drug Users
  The Journal of Infectious Diseases, 1996
• Co‐infection with HIV‐1/ HTLV‐II and the risk of progression to AIDS and death
  APMIS, 1996
• Seroprevalence of Human T Cell Lymphotropic Virus Type II Infection, with or without Human Immunodeficiency Virus Type 1 Coinfection, among US Intravenous Drug Users
  The Journal of Infectious Diseases, 1995
• Identification of IIa and IIb Molecular Subtypes of Human T-Cell Lymphotropic Virus Type II Among Italian Injecting Drug Users
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
• The impact of human T-lymphotrophic virus type I/II infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome
  Archives of internal medicine (1960), 1992
• Seroprevalence of HTLV-I and HTLV-II among Intravenous Drug Users and Persons in Clinics for Sexually Transmitted Diseases
  New England Journal of Medicine, 1992